Our newest episode features Seth Feuerstein ‘94, founder of Oui Therapeutics, a company developing a digital therapeutic going through the FDA process and seeking to be the first prescription product available for people at risk of dying by suicide.

A psychiatrist and an attorney, Seth is also the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.

We talk about the incredible impact this new product could have and about Seth's other digital health companies.